News

Bristol Myers shuffles its executive ranks with new CMO
AstraZeneca’s top medical executive Cristian Massacesi will replace Bristol Myers’ current chief medical officer, Samit ...
Bristol Myers’ Top Doctor Exits in Midst of Search for New Hit Drug
Bristol-Myers Squibb Co.’s chief medical officer is stepping down from his role after six years at the company, a surprise ...
Fierce Pharma3d
Roche CEO weighs direct-to-consumer drug sales to ease US drug pricing woes, cut out middlemen
A direct-to-consumer program for its drugs could bring down higher U.S. drug prices while cutting out pharmacy benefit ...
Roche Weighs Selling Drugs Directly to Patients in Bid to Lower U.S. Prices — Update
Pharmaceutical companies have been in talks with the U.S. government to figure out how to bring drug prices down after President Trump signed in May an executive order that ties U.S. prices to the ...
Zacks Investment Research on MSN3d
Bristol Myers Gains 6.3% in a Month: Buy, Sell or Hold the Stock?
Bristol Myers (BMY) delivered an impressive performance in the past month after being under pressure for quite some time. The ...
Jim Cramer Praises Lowe's CEO, As For CrowdStrike: 'I'll See You At $1000'
On CNBC's "Mad Money Lightning Round," Jim Cramer praised home improvement retailer Lowe's Companies and CrowdStrike Holdings ...
Roche eyes direct-to-patient sales in U.S. to avoid pharma middlemen
Roche (RHHBY) plans direct-to-patient drug sales in the U.S. to avoid the influence from pharmacy benefit managers in product ...
Jim Cramer on Bristol-Myers: “Never Seen it This Cheap”
Bristol-Myers Squibb Company (NYSE:BMY) is one of the stocks Jim Cramer reflected on. When asked about the stock during the ...